Trade XGN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Exagen Inc. (XGN) is trading at US$7.45, down 0.93% today as of Aug 28, 13:24 EDT. The company has a market capitalisation of US$191.86M. Over the past 52 weeks, XGN has traded between US$2.59 and US$12.23. On Syfe you can trade XGN with $0 commission and add it to your watchlist.
| Previous close | US$7.52 |
|---|---|
| Market cap | US$191.86M |
| 52-week range | US$2.59 – US$12.23 |
| Volume | 161.65K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Exagen Inc.
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Year: 2019
Roth Capital Initiates Exagen at Buy With $8 Price Target
Jun 25, 11:24 AM · MT Newswires
Exagen Inc. (XGN) stock is trading at US$7.45, -0.93% from the previous close of US$7.52.
The market cap for Exagen Inc. (XGN) stock is approximately US$191.86M.
The 52-week high for Exagen Inc. (XGN) stock is US$12.23.
The 52-week low for Exagen Inc. (XGN) stock is US$2.59.
Exagen Inc. (XGN) does not currently pay a dividend.
Stay on top of XGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
